| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to Active Surveillance Protocols: Well Meant but Overconcerned?
|
van den Bergh, Roderick C.N.
|
|
|
|
2 |
p. 202-203
|
artikel
|
| 2 |
Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis
|
Sonbol, Mohamad B.
|
|
|
|
2 |
p. 101-108
|
artikel
|
| 3 |
A Fully Automated Artificial Intelligence System to Assist Pathologists’ Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning
|
Tsuji, Keisuke
|
|
|
|
2 |
p. 258-265
|
artikel
|
| 4 |
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
|
Rentsch, Cyrill A.
|
|
|
|
2 |
p. 195-202
|
artikel
|
| 5 |
Are Multiparametric Magnetic Resonance Imaging and Guided Biopsies Needed in Men with Normal Digital Rectal Examination and Prostatic-specific Antigen >20 ng/ml?
|
Morote, Juan
|
|
|
|
2 |
p. 334-335
|
artikel
|
| 6 |
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study
|
Downer, Mary K.
|
|
|
|
2 |
p. 126-134
|
artikel
|
| 7 |
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
|
Fischer-Valuck, Benjamin W.
|
|
|
|
2 |
p. 246-250
|
artikel
|
| 8 |
A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines
|
de Jong, Joep J.
|
|
|
|
2 |
p. 183-189
|
artikel
|
| 9 |
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
|
Moore, Caroline M.
|
|
|
|
2 |
p. 160-182
|
artikel
|
| 10 |
Changes in Magnetic Resonance Imaging Using the Prostate Cancer Radiologic Estimation of Change in Sequential Evaluation Criteria to Detect Prostate Cancer Progression for Men on Active Surveillance
|
O’Connor, Luke P.
|
|
|
|
2 |
p. 227-234
|
artikel
|
| 11 |
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial
|
Rini, Brian I.
|
|
|
|
2 |
p. 225-234
|
artikel
|
| 12 |
Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One
|
Montironi, Rodolfo
|
|
|
|
2 |
p. 331-333
|
artikel
|
| 13 |
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer
|
Chalfin, Heather J.
|
|
|
|
2 |
p. 310-314
|
artikel
|
| 14 |
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
|
Messina, Carlo
|
|
|
|
2 |
p. 179-188
|
artikel
|
| 15 |
Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy
|
Bravi, Carlo Andrea
|
|
|
|
2 |
p. 323-326
|
artikel
|
| 16 |
Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies
|
Yakirevich, Evgeny
|
|
|
|
2 |
p. 282-288
|
artikel
|
| 17 |
Concurrent Stereotactic Ablative Radiotherapy and Antiangiogenic Targeted Agents: Redefining the Therapeutic Strategy
|
Rizzo, Mimma
|
|
|
|
2 |
p. 212-213
|
artikel
|
| 18 |
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
|
Sumanasuriya, Semini
|
|
|
|
2 |
p. 151-159
|
artikel
|
| 19 |
Contents
|
|
|
|
|
2 |
p. iii-vi
|
artikel
|
| 20 |
Contents
|
|
|
|
|
2 |
p. iii-vii
|
artikel
|
| 21 |
Contents
|
|
|
|
|
2 |
p. iii-v
|
artikel
|
| 22 |
Contents
|
|
|
|
|
2 |
p. iii-iv
|
artikel
|
| 23 |
Contents
|
|
|
|
|
2 |
p. iii-v
|
artikel
|
| 24 |
Contents
|
|
|
|
|
2 |
p. iii-vi
|
artikel
|
| 25 |
Contents
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 26 |
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor–targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data
|
de Bruijn, Roderick
|
|
|
|
2 |
p. 168-173
|
artikel
|
| 27 |
Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review
|
Kith, Glenda
|
|
|
|
2 |
p. 192-201
|
artikel
|
| 28 |
Defining “High Risk” for Men with Localized Prostate Cancer: How Close Can Clinical Parameters Get Us?
|
Mason, Ross J.
|
|
|
|
2 |
p. 149-150
|
artikel
|
| 29 |
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy
|
Martini, Alberto
|
|
|
|
2 |
p. 301-304
|
artikel
|
| 30 |
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)
|
Marchioni, Michele
|
|
|
|
2 |
p. 256-263
|
artikel
|
| 31 |
Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review
|
Lommen, Kim
|
|
|
|
2 |
p. 215-226
|
artikel
|
| 32 |
Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
|
Wang, Shu
|
|
|
|
2 |
p. 189-203
|
artikel
|
| 33 |
Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer
|
Wang, Yingqi
|
|
|
|
2 |
p. 237-245
|
artikel
|
| 34 |
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer
|
Tolmeijer, Sofie H.
|
|
|
|
2 |
p. 282-291
|
artikel
|
| 35 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 36 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 37 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 39 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 40 |
Editorial Board
|
|
|
|
|
2 |
p. i-ii
|
artikel
|
| 41 |
Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer
|
Roberts, Morgan E.
|
|
|
|
2 |
p. 214-215
|
artikel
|
| 42 |
Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models
|
Pecoraro, Alessio
|
|
|
|
2 |
p. 137-147
|
artikel
|
| 43 |
Expanding Active Surveillance Inclusion Criteria: A Novel Nomogram Including Preoperative Clinical Parameters and Magnetic Resonance Imaging Findings
|
Lantz, Anna
|
|
|
|
2 |
p. 187-194
|
artikel
|
| 44 |
Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care
|
Bochner, Bernard H.
|
|
|
|
2 |
p. 250-251
|
artikel
|
| 45 |
Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review
|
Stabile, Armando
|
|
|
|
2 |
p. 145-167
|
artikel
|
| 46 |
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
|
Labanca, Estefania
|
|
|
|
2 |
p. 164-175
|
artikel
|
| 47 |
From an On-site Program to a Mobile App for Prehabilitation and Rehabilitation for Robotic Radical Prostatectomy: Lessons Learned from 5 Years of Experience, the COVID-19 Outbreak, and Comparison with Nationwide Data
|
Ploussard, Guillaume
|
|
|
|
2 |
p. 297-299
|
artikel
|
| 48 |
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)
|
Heetman, Joris G.
|
|
|
|
2 |
p. 204-210
|
artikel
|
| 49 |
Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy
|
Sfakianos, John P.
|
|
|
|
2 |
p. 170-179
|
artikel
|
| 50 |
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon–degrading Bacteria Among Bladder Cancer Patients
|
Bukavina, Laura
|
|
|
|
2 |
p. 190-203
|
artikel
|
| 51 |
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy
|
Mossanen, Matthew
|
|
|
|
2 |
p. 143-148
|
artikel
|
| 52 |
How Should I Manage a Patient with Tumor Recurrence Despite Adequate Bacille Calmette-Guérin?
|
Kamat, Ashish M.
|
|
|
|
2 |
p. 252-257
|
artikel
|
| 53 |
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?
|
Vickers, Andrew J.
|
|
|
|
2 |
p. 135-137
|
artikel
|
| 54 |
Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer
|
Capitanio, Umberto
|
|
|
|
2 |
p. 209-215
|
artikel
|
| 55 |
Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer
|
Sutera, Philip
|
|
|
|
2 |
p. 241-247
|
artikel
|
| 56 |
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival
|
Saunders, Edward J.
|
|
|
|
2 |
p. 248-257
|
artikel
|
| 57 |
Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer
|
Taber, Ann
|
|
|
|
2 |
p. 203-213
|
artikel
|
| 58 |
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers
|
Guillamón, Concepción F.
|
|
|
|
2 |
p. 246-255
|
artikel
|
| 59 |
Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis
|
Cacciamani, Giovanni E.
|
|
|
|
2 |
p. 134-149
|
artikel
|
| 60 |
Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?
|
Mottet, Nicolas
|
|
|
|
2 |
p. 259-260
|
artikel
|
| 61 |
Incidental Prostate Cancer (cT1a–cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines
|
Capitanio, Umberto
|
|
|
|
2 |
p. 256-258
|
artikel
|
| 62 |
Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study
|
Celhay, Olivier
|
|
|
|
2 |
p. 198-206
|
artikel
|
| 63 |
Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation
|
Tanaka, Hajime
|
|
|
|
2 |
p. 264-273
|
artikel
|
| 64 |
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer
|
Alhalabi, Omar
|
|
|
|
2 |
p. 228-232
|
artikel
|
| 65 |
Kidney Cancer and Surgical Metastasectomy: Effective Therapy or Part of Disease Natural History?
|
Russo, Paul
|
|
|
|
2 |
p. 150-151
|
artikel
|
| 66 |
Let’s Follow the Golden Mean: Using Magnetic Resonance Imaging to Determine the Need for Biopsy in Men on Active Surveillance
|
Moore, Caroline M.
|
|
|
|
2 |
p. 235-236
|
artikel
|
| 67 |
Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review
|
de Kruijff, Ingeborg E.
|
|
|
|
2 |
p. 204-214
|
artikel
|
| 68 |
Liquid Biopsies Will Drive Treatment Decisions in the Future
|
Cendejas-Gomez, J. Jesus
|
|
|
|
2 |
p. 177-178
|
artikel
|
| 69 |
Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy
|
Zaffuto, Emanuele
|
|
|
|
2 |
p. 169-175
|
artikel
|
| 70 |
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non–muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience
|
Contieri, Roberto
|
|
|
|
2 |
p. 251-255
|
artikel
|
| 71 |
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor
|
Nason, Gregory J.
|
|
|
|
2 |
p. 289-296
|
artikel
|
| 72 |
Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United States
|
Royce, Trevor J.
|
|
|
|
2 |
p. 337-338
|
artikel
|
| 73 |
Magnetic Resonance Imaging–guided Focal Boost to Intraprostatic Lesions Using External Beam Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis
|
Poon, Darren M.C.
|
|
|
|
2 |
p. 116-127
|
artikel
|
| 74 |
Management of Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy: A Systematic Review of the Literature
|
Ploussard, Guillaume
|
|
|
|
2 |
p. 150-169
|
artikel
|
| 75 |
Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?
|
Bersanelli, Melissa
|
|
|
|
2 |
p. 274-281
|
artikel
|
| 76 |
Metastatic Sites’ Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review
|
Mattana, Francesco
|
|
|
|
2 |
p. 128-136
|
artikel
|
| 77 |
Neoadjuvant 177Lu-PSMA-I&T Radionuclide Treatment in Patients with High-risk Prostate Cancer Before Radical Prostatectomy: A Single-arm Phase 1 Trial
|
Golan, Shay
|
|
|
|
2 |
p. 151-159
|
artikel
|
| 78 |
New Landmarks Towards Reducing the Treatment Burden for Patients with a Postchemotherapy Residual Retroperitoneal Mass from Nonseminomatous Germ-cell Testicular Tumors
|
Nicolai, Nicola
|
|
|
|
2 |
p. 244-245
|
artikel
|
| 79 |
Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer
|
Stabile, Armando
|
|
|
|
2 |
p. 120-128
|
artikel
|
| 80 |
Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review
|
Battaglia, Antonino
|
|
|
|
2 |
p. 174-188
|
artikel
|
| 81 |
Off-clamp Versus On-clamp Partial Nephrectomy: Re-envision of a Dilemma
|
Bertolo, Riccardo
|
|
|
|
2 |
p. 173-176
|
artikel
|
| 82 |
Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial
|
Armstrong, Andrew J.
|
|
|
|
2 |
p. 292-296
|
artikel
|
| 83 |
Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting
|
Aluwini, Shafak S.
|
|
|
|
2 |
p. 231-238
|
artikel
|
| 84 |
PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes
|
Davidsson, Sabina
|
|
|
|
2 |
p. 214-221
|
artikel
|
| 85 |
Perioperative Immunotherapy in Muscle-invasive Bladder Cancer
|
Tripathi, Abhishek
|
|
|
|
2 |
p. 131-133
|
artikel
|
| 86 |
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
|
Hannan, Raquibul
|
|
|
|
2 |
p. 216-224
|
artikel
|
| 87 |
Positive Prostate-specific Membrane Antigen Findings: How To Interpret Them
|
Pomykala, Kelsey L.
|
|
|
|
2 |
p. 113-115
|
artikel
|
| 88 |
Prediction of Renal Function after Radical and Partial Nephrectomy: An Argument for Conceptual Simplicity
|
Rathi, Nityam
|
|
|
|
2 |
p. 148-150
|
artikel
|
| 89 |
Primum Non Nocere: When Nephrectomy Becomes a Selective Approach in Metastatic Renal Cell Carcinoma
|
Méjean, Arnaud
|
|
|
|
2 |
p. 174-175
|
artikel
|
| 90 |
Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
|
Egevad, Lars
|
|
|
|
2 |
p. 213-221
|
artikel
|
| 91 |
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non–muscle-invasive Spectrum
|
Beijert, Irene J.
|
|
|
|
2 |
p. 214-221
|
artikel
|
| 92 |
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study
|
van Rhijn, Bas W.G.
|
|
|
|
2 |
p. 182-191
|
artikel
|
| 93 |
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer
|
Berghen, Charlien
|
|
|
|
2 |
p. 305-309
|
artikel
|
| 94 |
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer
|
Touijer, Karim A.
|
|
|
|
2 |
p. 166-173
|
artikel
|
| 95 |
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy
|
Mannaerts, Christophe K.
|
|
|
|
2 |
p. 109-117
|
artikel
|
| 96 |
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer
|
Meijer, Dennie
|
|
|
|
2 |
p. 146-152
|
artikel
|
| 97 |
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial
|
Johansson, Eva
|
|
|
|
2 |
p. 134-142
|
artikel
|
| 98 |
Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer
|
Wu, Yishuo
|
|
|
|
2 |
p. 224-230
|
artikel
|
| 99 |
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
|
Loo Gan, Chun
|
|
|
|
2 |
p. 204-211
|
artikel
|
| 100 |
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists
|
Kim, Simon P.
|
|
|
|
2 |
p. 189-195
|
artikel
|
| 101 |
Re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266–274
|
Roussel, Eduard
|
|
|
|
2 |
p. 304-305
|
artikel
|
| 102 |
Re: Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol 2021;4:927–42
|
Chiang, Cho-Han
|
|
|
|
2 |
p. 263-264
|
artikel
|
| 103 |
Re: Felix Seelemeyer, David Pfister, Robert Pappesch, et al. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
|
Urabe, Fumihiko
|
|
|
|
2 |
p. 307
|
artikel
|
| 104 |
Re: Gopal Sharma, Milap Shah, Puneet Ahluwalia, et al. Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Propensity-matched Analysis. Eur Urol Oncol. 2023;6:525–530
|
Bertolo, Riccardo
|
|
|
|
2 |
p. 309-310
|
artikel
|
| 105 |
Re: Jonas Hugosson, Marianne Månsson, Jona Wallström, et al. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med 2022;387:2126–37
|
Lenfant, Louis
|
|
|
|
2 |
p. 235
|
artikel
|
| 106 |
Re: Jonas Hugosson, Marianne Månsson, Jona Wallström, et al. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med 2022;387:2126–37
|
Morote, Juan
|
|
|
|
2 |
p. 234
|
artikel
|
| 107 |
Re: Kristian D. Stensland, Harras Zaid, Mark Broadwin, et al. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2018.11.003
|
Moschini, Marco
|
|
|
|
2 |
p. 230
|
artikel
|
| 108 |
Rely on Your Eyes or on Your Mind? How Magnetic Resonance Imaging Before First Biopsy Could Become Feasible
|
Walz, Jochen
|
|
|
|
2 |
p. 118-119
|
artikel
|
| 109 |
Re: Mathieu Rouanne, Dean F. Bajorin, Raquibul Hannan, et al. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder. Eur Urol Oncol 2020;3:728–38
|
Montorsi, Francesco
|
|
|
|
2 |
p. 336
|
artikel
|
| 110 |
Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al’s Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266–274
|
Abel, E. Jason
|
|
|
|
2 |
p. 302-303
|
artikel
|
| 111 |
Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia’s Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596
|
Contieri, Roberto
|
|
|
|
2 |
p. 301
|
artikel
|
| 112 |
Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura’s Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021
|
Seelemeyer, Felix
|
|
|
|
2 |
p. 306
|
artikel
|
| 113 |
Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai’s Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629–634
|
Giganti, Francesco
|
|
|
|
2 |
p. 308
|
artikel
|
| 114 |
Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192–8
|
Ennis, Ronald D.
|
|
|
|
2 |
p. 226-227
|
artikel
|
| 115 |
Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192–8
|
Kishan, Amar U.
|
|
|
|
2 |
p. 224-225
|
artikel
|
| 116 |
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press
|
Capitanio, Umberto
|
|
|
|
2 |
p. 261-262
|
artikel
|
| 117 |
Requiem for Open Radical Cystectomy in Bladder Cancer Patients
|
Gandaglia, Giorgio
|
|
|
|
2 |
p. 196-197
|
artikel
|
| 118 |
Re: Ricardo G. Alvim, François Audenet, Emily A. Vertosick, Daniel D. Sjoberg, Karim A. Touijer. Performance Prediction for Surgical Outcomes in Partial Nephrectomy Using Nephrometry Scores: A Comparison of Arterial Based Complexity (ABC), RENAL, and PADUA Systems. Eur Urol Oncol 2018;1:428–34
|
Muttin, Fabio
|
|
|
|
2 |
p. 228-229
|
artikel
|
| 119 |
Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596
|
Montorsi, Francesco
|
|
|
|
2 |
p. 300
|
artikel
|
| 120 |
Re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192–8
|
Krimphove, Marieke J.
|
|
|
|
2 |
p. 222-223
|
artikel
|
| 121 |
Re: Yosuke Yasuda, J.J.H. Zhang, Worapat Attawettayanon, et al. Comprehensive Management of Renal Masses in Solitary Kidneys. Eur Urol Oncol. 2023;6:84–94
|
Chen, Kuan-Yu
|
|
|
|
2 |
p. 233
|
artikel
|
| 122 |
Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer Patients
|
Oliva, Lucía
|
|
|
|
2 |
p. 315-318
|
artikel
|
| 123 |
Robot-assisted Simple Enucleation Versus Standard Robot-assisted Partial Nephrectomy for Low- or Intermediate-complexity, Clinical T1 Renal Tumors: A Randomized Controlled Noninferiority Trial
|
Lu, Qun
|
|
|
|
2 |
p. 275-281
|
artikel
|
| 124 |
Should Upper-tract Urothelial Carcinoma and Bladder Carcinoma Be Treated the Same or Different?
|
Jain, Rohit K.
|
|
|
|
2 |
p. 180-181
|
artikel
|
| 125 |
Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer: Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment
|
Heidenreich, Axel
|
|
|
|
2 |
p. 211-212
|
artikel
|
| 126 |
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
|
Ratti, Maria Monica
|
|
|
|
2 |
p. 153-163
|
artikel
|
| 127 |
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review
|
Ouzaid, Idir
|
|
|
|
2 |
p. 141-149
|
artikel
|
| 128 |
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients
|
Williams, Stephen B.
|
|
|
|
2 |
p. 91-100
|
artikel
|
| 129 |
Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
|
Williams, Stephen B.
|
|
|
|
2 |
p. 119-125
|
artikel
|
| 130 |
The Efficacy and Safety of Relugolix Compared with Degarelix in Advanced Prostate Cancer Patients: A Network Meta-analysis of Randomized Trials
|
Sari Motlagh, Reza
|
|
|
|
2 |
p. 138-145
|
artikel
|
| 131 |
The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy
|
Kasabwala, Khushabu
|
|
|
|
2 |
p. 135-140
|
artikel
|
| 132 |
The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration
|
Morote, Juan
|
|
|
|
2 |
p. 311
|
artikel
|
| 133 |
Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments
|
Farolfi, Andrea
|
|
|
|
2 |
p. 152-162
|
artikel
|
| 134 |
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features
|
Abel, E. Jason
|
|
|
|
2 |
p. 266-274
|
artikel
|
| 135 |
Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography
|
Smith, Clayton P.
|
|
|
|
2 |
p. 224-227
|
artikel
|
| 136 |
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes
|
Chappidi, Meera R.
|
|
|
|
2 |
p. 222-230
|
artikel
|
| 137 |
Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution
|
Bertolo, Riccardo
|
|
|
|
2 |
p. 207-213
|
artikel
|
| 138 |
Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer
|
Preisser, Felix
|
|
|
|
2 |
p. 160-168
|
artikel
|
| 139 |
Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016
|
Ong, Wee Loon
|
|
|
|
2 |
p. 319-322
|
artikel
|
| 140 |
Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer
|
Chao, Brian
|
|
|
|
2 |
p. 129-133
|
artikel
|
| 141 |
Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer
|
Wang, Chenyang
|
|
|
|
2 |
p. 327-330
|
artikel
|
| 142 |
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
|
Gerdtsson, Axel
|
|
|
|
2 |
p. 235-243
|
artikel
|
| 143 |
Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile
|
Hoffman-Censits, Jean
|
|
|
|
2 |
p. 297-300
|
artikel
|
| 144 |
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study
|
Ahdoot, Michael
|
|
|
|
2 |
p. 176-186
|
artikel
|
| 145 |
Where To Draw the Line: Stratifying Risk for High-grade Ta Bladder Cancer
|
St-Laurent, Marie-Pier
|
|
|
|
2 |
p. 222-223
|
artikel
|
| 146 |
Where to Next for Theranostics in Prostate Cancer?
|
Murphy , Declan G.
|
|
|
|
2 |
p. 163-165
|
artikel
|
| 147 |
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters
|
Mazzone, Elio
|
|
|
|
2 |
p. 231-240
|
artikel
|
Tijdschrift beschrijving